149 related articles for article (PubMed ID: 35101249)
1. Mechanisms of Compound Kushen Injection for the treatment of bladder cancer based on bioinformatics and network pharmacology with experimental validation.
Zhang LH; Zhang WY; Xiong JM; Duan XM; Hai LN; Zhang YL; Zhang MM; Qin GF; Zhang GW
Chin J Nat Med; 2022 Jan; 20(1):43-53. PubMed ID: 35101249
[TBL] [Abstract][Full Text] [Related]
2. Network Pharmacology-Based Study on the Molecular Biological Mechanism of Action for Compound Kushen Injection in Anti-Cancer Effect.
He R; Ou S; Chen S; Ding S
Med Sci Monit; 2020 Jan; 26():e918520. PubMed ID: 31892693
[TBL] [Abstract][Full Text] [Related]
3. Compound Kushen injection inhibits EMT of gastric cancer cells via the PI3K/AKT pathway.
Li L; Wang K; Liu Z; Lü Y; Wang C; Yi X; Guo J
World J Surg Oncol; 2022 May; 20(1):161. PubMed ID: 35590327
[TBL] [Abstract][Full Text] [Related]
4. An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification.
Lu S; Meng Z; Tan Y; Wu C; Huang Z; Huang J; Fu C; Stalin A; Guo S; Liu X; You L; Li X; Zhang J; Zhou W; Zhang X; Wang M; Wu J
BMC Complement Med Ther; 2022 Mar; 22(1):54. PubMed ID: 35236335
[TBL] [Abstract][Full Text] [Related]
5. Elucidating the pharmacological effects of Compound Kushen injection on MYC-P15-CCND1 signaling pathway in nasopharyngeal carcinoma - An in vitro study.
Wu Z; Wu C; Shi J; Huang Z; Lu S; Tan Y; You R; Hai L; Huang J; Guo S; Gao Y; Jin Z; Tao X; You L; Wu J
J Ethnopharmacol; 2023 Oct; 315():116702. PubMed ID: 37257705
[TBL] [Abstract][Full Text] [Related]
6. Exploring the pharmacological mechanism of compound kushen injection in the treatment of breast cancer using
Ye Y; Zhang B; Liang Q; Wang D; Bai F; Li Y; Wei L; Li L; Huang H; Tang Y
Front Oncol; 2022; 12():946758. PubMed ID: 36016606
[TBL] [Abstract][Full Text] [Related]
7. A network pharmacology approach to reveal the pharmacological targets and biological mechanism of compound kushen injection for treating pancreatic cancer based on WGCNA and in vitro experiment validation.
Wu C; Huang ZH; Meng ZQ; Fan XT; Lu S; Tan YY; You LM; Huang JQ; Stalin A; Ye PZ; Wu ZS; Zhang JY; Liu XK; Zhou W; Zhang XM; Wu JR
Chin Med; 2021 Nov; 16(1):121. PubMed ID: 34809653
[TBL] [Abstract][Full Text] [Related]
8. Study on the mechanisms of compound Kushen injection for the treatment of gastric cancer based on network pharmacology.
Zhou W; Wu J; Zhu Y; Meng Z; Liu X; Liu S; Ni M; Jia S; Zhang J; Guo S
BMC Complement Med Ther; 2020 Jan; 20(1):6. PubMed ID: 32020871
[TBL] [Abstract][Full Text] [Related]
9. An Advanced Systems Pharmacology Strategy Reveals
Zhou W; Wu C; Zhao C; Huang Z; Lu S; Fan X; Tan Y; Stalin A; You R; Liu X; Zhang J; Wu Z; Wu J
Front Cell Dev Biol; 2021; 9():742421. PubMed ID: 34646828
[TBL] [Abstract][Full Text] [Related]
10. A Bioinformatics Research on Novel Mechanism of Compound Kushen Injection for Treating Breast Cancer by Network Pharmacology and Molecular Docking Verification.
Liu S; Hu X; Fan X; Jin R; Yang W; Geng Y; Wu J
Evid Based Complement Alternat Med; 2020; 2020():2758640. PubMed ID: 32849897
[TBL] [Abstract][Full Text] [Related]
11. Integrated bioinformatics analysis to decipher molecular mechanism of compound Kushen injection for esophageal cancer by combining WGCNA with network pharmacology.
Zhou W; Wu J; Zhang J; Liu X; Guo S; Jia S; Zhang X; Zhu Y; Wang M
Sci Rep; 2020 Jul; 10(1):12745. PubMed ID: 32728182
[TBL] [Abstract][Full Text] [Related]
12. Uncovering the anticancer mechanism of Compound Kushen Injection against HCC by integrating quantitative analysis, network analysis and experimental validation.
Gao L; Wang KX; Zhou YZ; Fang JS; Qin XM; Du GH
Sci Rep; 2018 Jan; 8(1):624. PubMed ID: 29330507
[TBL] [Abstract][Full Text] [Related]
13. Molecular Evidence of Compound Kushen Injection Against Lung Cancer: A Network Pharmacology-Based Investigation from Western Medicine to Traditional Medicine.
Liang S; Li Y; Zhang X; Guo Y; Pan S
Anticancer Agents Med Chem; 2021; 21(15):2012-2022. PubMed ID: 33573576
[TBL] [Abstract][Full Text] [Related]
14. A metabolic data-driven systems pharmacology strategy for decoding and validating the mechanism of Compound Kushen Injection against HCC.
Wang KX; Chen YP; Lu AP; Du GH; Qin XM; Guan DG; Gao L
J Ethnopharmacol; 2021 Jun; 274():114043. PubMed ID: 33753143
[TBL] [Abstract][Full Text] [Related]
15. Network-based Pharmacology and
Long X; Chen L; Yang J; Dong T; Cheng Q; Wang W; Zou Y; Su Y; Dai W; Chen B; Zhou X
Anticancer Agents Med Chem; 2023; 23(7):847-857. PubMed ID: 36305128
[TBL] [Abstract][Full Text] [Related]
16. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
[TBL] [Abstract][Full Text] [Related]
17. The feasibility of using the compound kushen injection to treat cervical cancer based on network pharmacology and transcriptomics.
Zhang Y; Xu L; Li L
Medicine (Baltimore); 2023 Sep; 102(36):e35135. PubMed ID: 37682145
[TBL] [Abstract][Full Text] [Related]
18. Potential mechanisms of osthole against bladder cancer cells based on network pharmacology, molecular docking, and experimental validation.
Jiang Y; Zhang M; Wang L; Zhang L; Ma M; Jing M; Li J; Song R; Zhang Y; Yang Z; Zhang Y; Pu Y; Qu X; Fan J
BMC Complement Med Ther; 2023 Apr; 23(1):122. PubMed ID: 37069622
[TBL] [Abstract][Full Text] [Related]
19. The potential mechanism of ursolic acid in the treatment of bladder cancer based on network pharmacology and molecular docking.
Huang XL; Sun Y; Wen P; Pan JC; He WY
J Int Med Res; 2024 Mar; 52(3):3000605241234006. PubMed ID: 38443785
[TBL] [Abstract][Full Text] [Related]
20. Combination of Compound Kushen Injection and cisplatin shows synergistic antitumor activity in p53-R273H/P309S mutant colorectal cancer cells through inducing apoptosis.
Wu X; Lu Y; Qin X
J Ethnopharmacol; 2022 Jan; 283():114690. PubMed ID: 34597653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]